This week’s recap highlights several significant FDA developments. We also cover ongoing successes of pembrolizumab with chemotherapy in NSCLC.

The U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and ...

1 In adjusted analyses, researchers found that omitting the 5-FU bolus from FOLFOX (leucovorin calcium, fluorouracil, and oxaliplatin), FOLFIRI (leucovorin calcium, fluorouracil, and irinotecan ...